India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on ...

Marketers are positioning weight-loss shots as cosmetic elixirs for anyone who wants to lose a few pounds. Doctors warn that ...

Doctors warn that microdosing copycat Ozempic and other GLP-1s is not approved for people with low BMIs and carries risks of ...

A large new trial falls short of experts’ expectations for combating the neurodegenerative disease. But there could still be ...

Danish drugmaker Novo Nordisk will launch its blockbuster diabetes drug Ozempic in India this month, three sources familiar ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.

Weight-loss jabs like Ozempic, Wegovy and Mounjaro started out as diabetes medications — but in the last few years, they’ve ...